[所有原性造血干细胞移植后的维持疗法]
Goichi Yoshimoto1, Toshihiro Miyamoto2
1Department of Hematology, Saga-Ken Medical Centre Koseikan.
概括
同源干细胞移植改善了血液癌症患者的生存率,但复发仍然是一个挑战. 维持疗法和新药是预防移植后复发的关键策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 全基性造血干细胞移植 (allo-HSCT) 为血液性恶性瘤患者提供了更好的生存率,特别是那些复发风险较高的患者.
- 艾洛-HSCT后疾病复发是治疗失败和死亡的主要原因,尽管存在化学疗法和供体淋巴细胞输液等治疗方法.
- 缓解复发的策略包括以可测量的残留疾病为指导的预防性治疗和高风险个体的维持疗法.
研究的目的:
- 审查当前的维护疗法的格局,以后的allo-HSCT.
- 探索未来的策略,以防止疾病复发后allo-HSCT.
- 专注于在AML和ALL的移植后环境中应用新型药物和细胞疗法.
主要方法:
- 对allo-HSCT的当前和新兴维持疗法的文献综述.
- 对具有高抗瘤活性和降低毒性的新药和细胞疗法的分析.
- 检查移植后急性髓性白血病 (AML) 和急性淋巴细胞白血病 (ALL) 的治疗策略.
主要成果:
- 维持疗法和基于可测量的残留疾病的预防性治疗是减少复发的关键策略.
- 新型药物和细胞疗法越来越多地被用于移植后的环境,因为它们的疗效和安全性.
- 该审查综合了当前的方法和AML和ALL在allo-HSCT后的维持治疗的未来方向.
结论:
- 维持疗法是巩固alo-HSCT结果和预防疾病复发的关键方法.
- 未来的战略可能包括将新型治疗剂和细胞疗法整合到移植后护理方案中.
- 持续的研究对于完善维护策略和改善移植后血液恶性瘤患者的存活率至关重要.
更多相关视频
相关概念视频
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:22Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
01:24Tissue Transplantation
415
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
415
01:40Cell-mediated Immune Responses
69.1K
Overview
69.1K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K